Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus

被引:16
作者
Fukui, Michiaki [1 ]
Shiraishi, Emi [1 ]
Tanaka, Muhei [1 ]
Senmaru, Takafumi [1 ]
Sakabe, Kazumi [1 ]
Harusato, Ichiko [1 ]
Hasegawa, Goji [1 ]
Nakamura, Naoto [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2009年 / 58卷 / 08期
关键词
PLATELET-AGGREGATION; MICROALBUMINURIA; RISK; MORTALITY;
D O I
10.1016/j.metabol.2009.03.009
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
We performed an observational study to investigate if plasma 5-hydroxyindole-3-acetic acid (5-HIAA), a derivative end product of serotonin (5-hydroxytryptamine), concentration could be a predictor for deterioration of urinary albumin excretion. The relationship between baseline plasma 5-HIAA concentration and changes in urinary albumin excretion for 24 months was investigated in 162 male patients with type 2 diabetes mellitus. Patients were divided into tertiles according to plasma 5-HIAA concentration. Greater changes in urinary albumin excretion were seen in patients with high plasma 5-HIAA concentration (112.8 +/- 36.2 mg/g creatinine) than in patients with low plasma 5-HIAA concentration (7.6 +/- 8.0 mg/g creatinine, P=.0011) or in patients with intermediate plasma 5-HIAA concentration (25.6 +/- 15.0 mg/g creatinine, P=.0070) after adjustment for baseline values of urinary albumin excretion. A positive correlation was observed between log (plasma 5-HIAA concentration) and changes in urinary albumin excretion (r=0.314, P<.0001). Multiple regression analysis demonstrated that log (plasma 5-HIAA concentration) (beta = .284, P = .0013) was an independent determinant of changes in urinary albumin excretion. In conclusion, plasma 5-HIAA concentration was positively correlated with changes in urinary albumin excretion, which may indicate causality in diabetic nephropathy in male patients with type 2 diabetes mellitus and high plasma 5-HIAA concentration. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1076 / 1079
页数:4
相关论文
共 19 条
[1]
Banes A, 1999, J PHARMACOL EXP THER, V291, P1179
[2]
INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE [J].
BARRADAS, MA ;
GILL, DS ;
FONSECA, VA ;
MIKHAILIDIS, DP ;
DANDONA, P .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) :399-404
[3]
Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0
[4]
The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus - A systematic overview of the literature [J].
Dinneen, SF ;
Gerstein, HC .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (13) :1413-1418
[5]
Gavin JR, 1999, DIABETES CARE, V22, pS5
[6]
Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
[7]
Serotonin enhances the production of type IV collagen by human mesangial cells [J].
Kasho, M ;
Sakai, M ;
Sasahara, T ;
Anami, Y ;
Matsumura, T ;
Takemura, T ;
Matsuda, H ;
Kobori, S ;
Shichiri, M .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1083-1092
[8]
SYNTHESES AND PLATELET-AGGREGATION INHIBITORY AND ANTITHROMBOTIC PROPERTIES OF [2-[(OMEGA-AMINOALKOXY)PHENYL]ETHYL]BENZENES [J].
KIKUMOTO, R ;
HARA, H ;
NINOMIYA, K ;
OSAKABE, M ;
SUGANO, M ;
FUKAMI, H ;
TAMAO, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1818-1823
[9]
KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465
[10]
HYPERINSULINEMIC MICROALBUMINURIA - A NEW RISK INDICATOR FOR CORONARY HEART-DISEASE [J].
KUUSISTO, J ;
MYKKANEN, L ;
PYORALA, K ;
LAAKSO, M .
CIRCULATION, 1995, 91 (03) :831-837